Bayview Pharmacy's Flurbiprofen 10%/Cyclobenzaprine HCl 1% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients. It is used to treat conditions such as osteoarthritis, tendinitis, bursitis, fibromyalgia, and myofascial pain syndrome.

Licensed to fill prescriptions for patients in RI, MA, CT, NY, NJ, NH, FL and ME.
Prescriber? Sign in or create an account for prescription details and order forms.
Bayview Pharmacy is pleased to present a specialized topical gel formulation of Flurbiprofen 10%/Cyclobenzaprine HCl 1%. This unique compound is specifically designed for the management of various musculoskeletal conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis.
Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID), functions by inhibiting the production of certain chemicals in the body that trigger inflammation and pain. On the other hand, Cyclobenzaprine HCl is a muscle relaxant that operates by blocking nerve impulses responsible for muscle spasms. The combination of these two medications in a gel form allows for targeted relief of pain and inflammation in the affected area.
This compounded formulation is a semisolid preparation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients. The gel-like consistency ensures that the medication is absorbed effectively into the skin, providing direct relief to the affected area.
The formulation can be applied up to four times a day for optimal results. However, it is crucial to remember that this formulation should not be used on broken or damaged skin. Additionally, patients with a history of gastrointestinal bleeding or ulcers should exercise caution when using this product.
If you have any queries about this Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel formulation or its application in treating Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, or Bursitis, please do not hesitate to contact us at Bayview Pharmacy.
This Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel is a compounded formulation designed for targeted treatment of various conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis. The gel contains Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammation and pain-causing chemicals in the body. It also contains Cyclobenzaprine HCl, a muscle relaxant that blocks nerve impulses responsible for muscle spasms.
It is crucial to note that this formulation is contraindicated in patients with known hypersensitivity to either Flurbiprofen or Cyclobenzaprine HCl. It should also be avoided by patients with a history of gastrointestinal bleeding or ulcer disease. Patients are advised to avoid contact with the eyes and mucous membranes when applying the gel.
The gel should be applied to the affected area two to three times daily, or as directed by a healthcare provider. It is not recommended for use beyond two weeks without medical consultation. Patients should be aware that this medication may affect their alertness and should avoid activities requiring alertness until they understand how the medication affects them. Concurrent consumption of alcohol while using this medication is not advised as it may increase the risk of side effects.
If you have any questions about this Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel formulation or its use in treating Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, or Bursitis, please do not hesitate to reach out for further information.
This Flurbiprofen 10%/Cyclobenzaprine HCl 1% topical gel is a semisolid formulation designed for targeted treatment of various conditions such as Fibromyalgia, Myofascial Pain Syndrome, Osteoarthritis, Tendonitis, and Bursitis. The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
Flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the production of certain chemicals in the body that cause inflammation and pain. Cyclobenzaprine HCl, on the other hand, is a muscle relaxant that functions by blocking nerve impulses that lead to muscle spasms. When combined and applied topically, these medications can effectively reduce inflammation and pain associated with the aforementioned conditions.
To use this topical gel, apply a thin layer to the affected area and gently massage until it is fully absorbed. It is crucial to wash your hands after applying the gel. Avoid applying the gel to broken or irritated skin and avoid contact with the eyes, nose, and mouth. Unless directed by your healthcare provider, do not cover the treated area with a bandage or other dressing.
Adherence to your healthcare provider’s instructions for using this medication is essential. Do not use more or less than prescribed and do not discontinue use without consulting your healthcare provider. If you have any questions or concerns about using this topical gel, do not hesitate to seek advice from a healthcare professional.
This compounded formulation of Flurbiprofen 10%/Cyclobenzaprine HCl 1% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, which allows for targeted treatment or absorption of the active ingredients. The gel-like consistency ensures that the medication is absorbed effectively through the skin, providing relief from a variety of musculoskeletal conditions. These include osteoarthritis, tendinitis, bursitis, fibromyalgia, and myofascial pain syndrome.
When using this formulation, it is crucial to apply it only to the affected area and not on open wounds or areas of skin that are broken or irritated. It is also important to avoid application on the face or around the eyes. After applying the gel, patients should wash their hands thoroughly to avoid accidental contact with the eyes. If any irritation or redness occurs, usage should be discontinued immediately and the healthcare provider should be contacted. This formulation is designed to provide targeted relief, and any adverse reactions should be reported promptly to ensure patient safety.
This is a semisolid formulation that contains Flurbiprofen and Cyclobenzaprine HCl as active ingredients. It is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin.
The gel has a semisolid, gel-like consistency that allows it to be easily spread on the skin for targeted treatment.
The active ingredients in the gel are absorbed through the skin to provide targeted treatment. Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation, while Cyclobenzaprine HCl is a muscle relaxant.
Apply the gel to the affected area as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
This gel is intended for external use only. Avoid contact with eyes, mouth, and other mucous membranes. If you have any specific questions about where to apply the gel, consult your healthcare provider.
If you experience any side effects such as skin irritation, redness, or rash, stop using the gel and contact your healthcare provider immediately.
If you are pregnant or breastfeeding, consult your healthcare provider before using this gel. The active ingredients may be absorbed through the skin and could potentially affect the baby.
Before using this gel, inform your healthcare provider about any other medications you are currently taking. Some medications may interact with the active ingredients in this gel, affecting their effectiveness or causing side effects.
Store this gel at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)